Intensity of statin therapy in primary and secondary prevention: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Hypercholesterolemia}} {{CMG}}; {{AE}} Kashish Goel, M.D. ==Overview== The intensity of statin therapy is defined on the basis of the average exp...")
 
mNo edit summary
Line 4: Line 4:


==Overview==
==Overview==
The intensity of statin therapy is defined on the basis of the average expected LDL–C response to a specific statin and dose. “High-intensity,” “moderate-intensity,” and “lower-intensity” statin therapy definitions were derived from the systematic reviews for CQ1 and CQ2. The basis for differentiation among specific statins and doses arose from the RCTs included in CQ1, where there was a high level of evidence that high-intensity statin therapy with atorvastatin 40 mg to 80 mg reduced ASCVD risk more than moderate-intensity statin therapy with atorvastatin 10 mg, pravastatin 40 mg, or simvastatin 20 mg to 40 mg bid. Classifying specific statins and doses by the percent reduction in LDL–C level is based on evidence that the relative reduction in ASCVD risk from statin therapy is related to the degree by which
The intensity of statin therapy is defined on the basis of the average expected LDL response to a specific statin and dose. High-intensity statin daily therapy lowers LDL by approximately ≥50%, moderate-intensity statin lowers LDL by approximately 30% to <50%, and lower-intensity statin lowers LDL by <30%.<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | url =http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a.full.pdf+html | publisher =  | date =  | accessdate = 13 November 2013 }}</ref>


 
==High-, Moderate-, and Low-Intensity Statin Therapy==
 
<ref name="circ.ahajournals.org">{{Cite web  | last =  | first =  | title = 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults | url =http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437738.63853.7a.full.pdf+html | publisher =  | date =  | accessdate = 13 November 2013 }}</ref>
 
==High- Moderate- and Low-Intensity Statin Therapy==


{| {{table}}
{| {{table}}
Line 16: Line 12:
| align="center" style="background:#f0f0f0;"|'''Moderate-Intensity Statin Therapy'''
| align="center" style="background:#f0f0f0;"|'''Moderate-Intensity Statin Therapy'''
| align="center" style="background:#f0f0f0;"|'''Low-Intensity Statin Therapy'''
| align="center" style="background:#f0f0f0;"|'''Low-Intensity Statin Therapy'''
|-
| Daily dose lowers LDL–C on average, <BR> by approximately ≥50%||Daily dose lowers LDL–C on average, <BR> by approximately 30% to <50%||Daily dose lowers LDL–C on average, <BR> by <30%
|-  
|-  
| valign="top" | '''Atorvastatin (40†)–80 mg''' <BR> '''Rosuvastatin 20 (40) mg''' || valign="top" | '''Atorvastatin 10 (20) mg''' <BR> '''Rosuvastatin (5) 10 mg''' <BR> '''Simvastatin 20–40 mg‡''' <BR> '''Pravastatin 40 (80) mg''' <BR> '''Lovastatin 40 mg''' <BR> Fluvastatin XL 80 mg <BR> '''Fluvastatin 40 mg bid''' <BR> Pitavastatin 2–4 mg || valign="top" |Simvastatin 10 mg <BR> '''Pravastatin 10–20 mg''' <BR> '''Lovastatin 20 mg''' <BR> Fluvastatin 20–40 mg <BR> Pitavastatin 1 mg
| valign="top" | '''Atorvastatin (40†)–80 mg''' <BR> '''Rosuvastatin 20 (40) mg''' || valign="top" | '''Atorvastatin 10 (20) mg''' <BR> '''Rosuvastatin (5) 10 mg''' <BR> '''Simvastatin 20–40 mg‡''' <BR> '''Pravastatin 40 (80) mg''' <BR> '''Lovastatin 40 mg''' <BR> Fluvastatin XL 80 mg <BR> '''Fluvastatin 40 mg bid''' <BR> Pitavastatin 2–4 mg || valign="top" |Simvastatin 10 mg <BR> '''Pravastatin 10–20 mg''' <BR> '''Lovastatin 20 mg''' <BR> Fluvastatin 20–40 mg <BR> Pitavastatin 1 mg

Revision as of 19:04, 13 November 2013

Template:Hypercholesterolemia Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kashish Goel, M.D.

Overview

The intensity of statin therapy is defined on the basis of the average expected LDL response to a specific statin and dose. High-intensity statin daily therapy lowers LDL by approximately ≥50%, moderate-intensity statin lowers LDL by approximately 30% to <50%, and lower-intensity statin lowers LDL by <30%.[1]

High-, Moderate-, and Low-Intensity Statin Therapy

High-Intensity Statin Therapy Moderate-Intensity Statin Therapy Low-Intensity Statin Therapy
Atorvastatin (40†)–80 mg
Rosuvastatin 20 (40) mg
Atorvastatin 10 (20) mg
Rosuvastatin (5) 10 mg
Simvastatin 20–40 mg‡
Pravastatin 40 (80) mg
Lovastatin 40 mg
Fluvastatin XL 80 mg
Fluvastatin 40 mg bid
Pitavastatin 2–4 mg
Simvastatin 10 mg
Pravastatin 10–20 mg
Lovastatin 20 mg
Fluvastatin 20–40 mg
Pitavastatin 1 mg

References

  1. "2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults". Retrieved 13 November 2013.


Template:WikiDoc Sources